| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Revenue | $20.6B | $19.7B | $19.6B |
| Cost of Revenue | — | — | — |
| Gross Profit | $8.2B | $8.2B | $7.9B |
| R&D Expense | $1.3B | $1.3B | $1.2B |
| SG&A Expense | $4.2B | $4.3B | $4.3B |
| Operating Income | $2.8B | $2.6B | $2.4B |
| Net Income | $2.1B | $2.0B | $1.6B |
| EPS (Basic) | $4.56 | $4.37 | $3.05 |
| EPS (Diluted) | $4.55 | $4.34 | $3.03 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Total Assets | $36.9B | $33.1B | $32.5B |
| Current Assets | $12.5B | $9.9B | $9.4B |
| Cash & Equivalents | $4.5B | $2.9B | $2.5B |
| Total Liabilities | $26.3B | $24.4B | $25.1B |
| Current Liabilities | $9.1B | $9.6B | $9.0B |
| Stockholders' Equity | $10.4B | $8.4B | $7.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Operating Cash Flow | — | — | — |
| Investing Cash Flow | $-1.0B | $-0.9B | $-0.6B |
| Capital Expenditures | — | — | — |
| Financing Cash Flow | $0.6B | $-0.6B | $-0.5B |